Sotera Health Company / Fundamentals
Income statement
- Net revenue
€970.51M - Cost of goods sold
€431.60M - Gross profit
€538.92M - SG&A expenses
€220.76M - R&D expenses
€0.00 - EBITDA
€358.76M - D&A
€137.88M - EBIT
€278.26M - Interest expenses
€141.59M - EBT
€79.22M - Tax expenses
€58.49M - Net income
€20.73M
Cash flow statement
- Net deferred tax
€7.34M - Non-cash items
€31.60M - Changes in working capital
€44.85M - Operating cash flow
€228.06M - Capex
€132.39M - Other investing cash flow
€63.86K - Net investing cash flow
-€132.33M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
-€6.51M - Other financing cash flow
-€12.79M - Net financing cash flow
-€19.31M - Foreign exchange effects
-€1.76M - Net change in cash
€74.66M - Cash at end of period
€288.49M - Free cash flow
€360.46M
Balance sheet
- Cash and cash equivalents
€286.91M - Cash and short-term investments
€286.91M - Total receivables
€155.16M - Inventory
€51.74M - Other current assets
€31.07M - Total current assets
€524.88M - Property, plant & equipment
€959.63M - Goodwill
€953.23M - Intangible assets
€259.00M - Long-term investments
€172.61K - Other non-current assets
€75.39M - Total non-current assets
€2.25B - Total assets
€2.78B - Accounts payable
€54.94M - Short-term debt
€20.42M - Other current liabilities
€123.88M - Total current liabilities
€212.58M - Long-term debt
€2.11B - Deferred tax liabilities
€41.48M - Other non-current liabilities
€58.34M - Total non-current liabilities
€2.12B - Total liabilities
€2.33B - Common stock
€2.47M - Retained earnings
-€531.06M - Other equity
-€93.46M - Total equity
€441.26M - Total liabilities and shareholders' equity
€2.78B
Company information
- Market capitalization
€2.74B - Employees
3K - Enterprise Value
€3.19B
Company ratios
- Gross margin
-
55.5% Better than peer group: 44.9% - EBITDA margin
-
37.0% Much better than peer group: -892.2% - EBIT margin
-
28.7% Much better than peer group: -962.9% - EBT margin
-
8.2% Much better than peer group: -953.5% - Net margin
-
2.1% Much better than peer group: -950.4% - ROE
-
4.7% Much worse than peer group: 106.7% - ROA
-
0.7% Better than peer group: -6.3% - Asset turnover
-
35.0% Much worse than peer group: 64.8% - FCF margin
-
9.9% Much better than peer group: -771.3% - FCF yield
3.5% - Efficiency ratio
63.0% - Net sales per employee
-
€323.50K - Net income per employee
-
€6.91K